Juan Francisco Arenillas Selected Research

Juan Francisco Arenillas Research Topics

6	Stroke (Strokes) 01/2022 - 01/2008
3	Inflammation (Inflammations) 01/2021 - 01/2008
2	Ischemic Stroke 01/2021 - 01/2008
1	Pathologic Constriction (Stenosis) 01/2023
1	Embolic Stroke 01/2022
1	Lymphopenia (Lymphocytopenia) 07/2020
1	COVID-19 07/2020
1	Anosmia 07/2020
1	Myalgia 07/2020
1	Fever (Fevers) 07/2020
1	Headache (Headaches) 07/2020
1	Cognitive Dysfunction 01/2020
1	Fatigue 03/2015
1	Multiple Sclerosis 03/2015
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2013
1	Insulin Resistance 01/2013
1	Thrombosis (Thrombus) 01/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 10/2012
1	Brain Ischemia (Cerebral Ischemia) 01/2008
1	Brain Injuries (Brain Injury) 01/2008

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2019
2	C-Reactive ProteinIBA 07/2020 - 01/2013
1	GadoliniumIBA 01/2023
1	AnticoagulantsIBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2021
1	NucleotidesIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 07/2020
1	InterferonsIBA 03/2015
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2013
1	Plasminogen Activator Inhibitor 1IBA 01/2013
1	ResistinIBA 01/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2008
1	IronIBA 01/2008
1	Fibronectins (Fibronectin)IBA 01/2008
1	Ferritins (Ferritin)IBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Glutamic Acid (Glutamate)FDA Link 01/2008